| PDF (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-211525
- DOI to cite this document:
- 10.5283/epub.21152
Abstract
51Cr-EDTA activity was measured in urine and blood of patients receiving non-steroidal anti-inflammatory (NSA) drug treatment and of healthy subjects and other patients (controls), after oral intake of 51Cr-EDTA, for the purpose of deciding whether NSA treatment increases urinary excretion of oral 51Cr-EDTA as an expression of increased intestinal permeability. 51Cr-EDTA activity in urine and ...
Owner only: item control page